Search This Blog

Monday, June 10, 2019

FDA OKs expanded use for Masimo’s O3 oximeter

The FDA grants 510(k) clearance for Masimo’s (MASI +4%) O3 Regional Oximetry for use on neonatal and infant patients (less than 10 kg). It was previously cleared for adult and pediatric patients.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.